KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Total Non-Current Liabilities: 2015-2025

Historic Total Non-Current Liabilities for Medpace Holdings (MEDP) over the last 9 years, with Sep 2025 value amounting to $1.4 billion.

  • Medpace Holdings' Total Non-Current Liabilities rose 19.88% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 19.88%. This contributed to the annual value of $1.2 billion for FY2024, which is 15.23% up from last year.
  • Medpace Holdings' Total Non-Current Liabilities amounted to $1.4 billion in Q3 2025, which was up 4.27% from $1.3 billion recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Total Non-Current Liabilities registered a high of $1.4 billion during Q3 2025, and its lowest value of $576.3 million during Q1 2021.
  • In the last 3 years, Medpace Holdings' Total Non-Current Liabilities had a median value of $1.1 billion in 2024 and averaged $1.2 billion.
  • Per our database at Business Quant, Medpace Holdings' Total Non-Current Liabilities skyrocketed by 68.68% in 2022 and then decreased by 2.17% in 2023.
  • Quarterly analysis of 5 years shows Medpace Holdings' Total Non-Current Liabilities stood at $689.3 million in 2021, then surged by 36.87% to $943.4 million in 2022, then increased by 13.38% to $1.1 billion in 2023, then increased by 15.23% to $1.2 billion in 2024, then grew by 19.88% to $1.4 billion in 2025.
  • Its last three reported values are $1.4 billion in Q3 2025, $1.3 billion for Q2 2025, and $1.3 billion during Q1 2025.